South River, NJ, United States of America

Joseph A Hedrick

This inventor holds 17 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Biopharmaceutical Research. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Canji Inc.. Active years: 2000-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph A Hedrick. Retrieved from https://idiyas.com/inventor/joseph-a-hedrick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 23.5

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 71(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (2000 - 2007)
  • South River, NJ (US) (2001 - 2015)

Company Filing History:


Years Active: 2000-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Matrilin-2 Polypeptide
Anti-PCSK9
Nucleic Acids
CCL27
Histamine Receptor
Adenosine Receptor
Cytokines
Th2 Cell Modulation
7 Transmembrane Receptor
Antibodies
Lymphotactin
Receptor Family
17 patents (USPTO):Explore Patents

Title: The Innovative Journey of Joseph A Hedrick: Revolutionizing Cholesterol Treatment

Introduction:

Joseph A Hedrick, a prolific inventor based in South River, NJ, has made significant strides in the field of healthcare with a total of 17 patents under his belt. His groundbreaking work has focused on treating lipid disorders and cholesterol-related conditions, showcasing a deep commitment to advancing medical science.

Latest Patents:

Hedrick's latest patents highlight his dedication to finding novel solutions for reducing total cholesterol levels. His method of administering matrilin-2 polypeptide to inhibit PCSK9 represents a pioneering approach in lipid disorder treatment. Additionally, his development of anti-PCSK9 compositions demonstrates his innovative thinking in addressing cholesterol and lipid metabolism disorders.

Career Highlights:

With a rich professional background, Joseph A Hedrick has lent his expertise to renowned companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His contributions have not only enhanced the reputation of these organizations but have also propelled advancements in the pharmaceutical industry.

Collaborations:

Throughout his career, Hedrick has collaborated with esteemed professionals in the field, including Albert Zlotnik and Frederick James Monsma, Jr. These partnerships have fostered a culture of innovation, leading to the development of cutting-edge solutions for complex healthcare challenges.

Conclusion:

In conclusion, Joseph A Hedrick stands as a testament to the power of innovation in driving positive change within the healthcare landscape. His relentless pursuit of inventive solutions and fruitful collaborations underscore his commitment to improving the lives of individuals grappling with lipid disorders and cholesterol imbalances. Hedrick's legacy of transformative inventions cements his status as a visionary inventor in the realm of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…